(GBLB) Groep Brussel Lambert - Ratings and Ratios
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0003797140
GBLB: Industrial, Consumer Goods, Business Services
Groupe Bruxelles Lambert SA is a diversified investment company with a portfolio that spans multiple sectors, including industrial, consumer goods, and business services. The company's investments are spread across various geographic regions, including Belgium, other European countries, North America, and international markets. This diversified approach allows the company to mitigate risk and capitalize on growth opportunities in different parts of the world. The company's portfolio is comprised of a range of companies operating in distinct sectors, providing a broad-based foundation for its investment activities.
The company's operations are organized into seven distinct segments, each with its own focus and strategy. The Holding segment serves as the core of the company's operations, overseeing the overall investment portfolio and providing strategic direction. Imerys is a leading manufacturer of mineral-based specialty materials, while Webhelp is a prominent provider of business process outsourcing services. Canyon and Affidea operate in the healthcare sector, with Canyon focused on medical equipment and Affidea providing diagnostic imaging services. Sanoptis is a healthcare company that offers a range of medical services, and GBL Capital and Sienna Investment Managers comprise the company's investment management arm, responsible for managing the company's investment portfolio and providing investment advisory services.
Groupe Bruxelles Lambert SA has a long history, dating back to its incorporation in 1902. The company is headquartered in Brussels, Belgium, and has established itself as a major player in the European investment landscape. With a strong track record of investing in a range of industries and sectors, the company has built a reputation for its disciplined investment approach and commitment to long-term value creation. The company's common stock is listed on the Euronext Brussels stock exchange, and its ISIN code is BE0003797140. As a multi-sector holdings company, Groupe Bruxelles Lambert SA is classified under the GICS Sub Industry category, reflecting its diversified investment portfolio and broad-based investment strategy.
The company's website, https://www.gbl.be, provides detailed information on its investment portfolio, company history, and governance structure. With a strong focus on transparency and accountability, the company provides regular updates on its financial performance and investment activities, allowing stakeholders to stay informed about its progress and strategic direction. As a leading investment company in Europe, Groupe Bruxelles Lambert SA is committed to delivering long-term value to its shareholders and stakeholders, while maintaining its position as a responsible and engaged corporate citizen.
Additional Sources for GBLB Stock
GBLB Stock Overview
Market Cap in USD | 8,481m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Multi-Sector Holdings |
IPO / Inception |
GBLB Stock Ratings
Growth 5y | -27.2% |
Fundamental | 48.3% |
Dividend | 39.7% |
Rel. Strength Industry | -97 |
Analysts | - |
Fair Price Momentum | 63.30 EUR |
Fair Price DCF | 75.84 EUR |
GBLB Dividends
Dividend Yield 12m | 4.16% |
Yield on Cost 5y | 3.45% |
Annual Growth 5y | -2.68% |
Payout Consistency | 98.6% |
GBLB Growth Ratios
Growth Correlation 3m | -25% |
Growth Correlation 12m | -26.6% |
Growth Correlation 5y | -25.8% |
CAGR 5y | -3.60% |
CAGR/Mean DD 5y | -0.20 |
Sharpe Ratio 12m | -0.49 |
Alpha | -21.30 |
Beta | 0.63 |
Volatility | 14.69% |
Current Volume | 85.9k |
Average Volume 20d | 99.3k |
As of January 22, 2025, the stock is trading at EUR 66.15 with a total of 85,855 shares traded.
Over the past week, the price has changed by +1.61%, over one month by +2.40%, over three months by -4.61% and over the past year by +1.06%.
Partly, yes. Based on ValueRay Fundamental Analyses, Groep Brussel Lambert (BR:GBLB) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 48.27 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GBLB as of January 2025 is 63.30. This means that GBLB is currently overvalued and has a potential downside of -4.31%.
Groep Brussel Lambert has no consensus analysts rating.
According to ValueRays Forecast Model, GBLB Groep Brussel Lambert will be worth about 68.4 in January 2026. The stock is currently trading at 66.15. This means that the stock has a potential upside of +3.34%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 89.8 | 35.8% |
Analysts Target Price | - | - |
ValueRay Target Price | 68.4 | 3.3% |